文献速递新发突发、热带与寄生虫病

刚果民主共和国与亚洲青蒿素疗效研究中抗体反应和寄生虫清除的比较

Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.
PubMed 文献 · J Infect Dis · 2022-01-01

在青蒿素疗效研究中,检测刚果民主共和国118例无并发症恶性疟患儿针对12种前红细胞期和红细胞期恶性疟抗原的抗体,并与亚洲站点患者比较。刚果民主共和国患者寄生虫清除半衰期中位数为2小时,短于多数亚洲站点的2-7小时,但恶性疟抗体水平和血清阳性率相似,且抗体血清阳性与清除半衰期无关联(血清阴性 vs 阳性平均差 -0.14 至 +0.40 小时)。

要点

  • 刚果民主共和国患儿寄生虫清除半衰期中位数为2小时,短于多数亚洲站点的2-7小时。
  • 刚果民主共和国与亚洲站点的恶性疟抗体水平和血清阳性率相似。
  • 刚果民主共和国患者中抗体血清阳性与寄生虫清除半衰期无关联(平均差 -0.14 至 +0.40 小时)。

核心结论

  • 在青蒿素仍高度有效的刚果民主共和国,寄生虫清除时间较亚洲大幅缩短,但所研究的恶性疟抗体反应差异不能解释这一现象。

研究设计与样本

  • 在青蒿素疗效研究中,检测刚果民主共和国118例无并发症恶性疟患儿针对12种前红细胞期和红细胞期恶性疟抗原的抗体,并与亚洲站点患者(数据另文描述)比较。

主要发现

  • 刚果民主共和国患者寄生虫清除半衰期中位数为2小时,多数亚洲站点为2-7小时。
  • 刚果民主共和国与亚洲站点的恶性疟抗体水平和血清阳性率相似。
  • 刚果民主共和国患者中抗体血清阳性与寄生虫清除半衰期无关联,血清阴性 vs 血清阳性平均差为 -0.14 至 +0.40 小时。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the effect of immunity on Plasmodium falciparum clearance is essential for interpreting therapeutic efficacy studies designed to monitor emergence of artemisinin drug resistance. In low-transmission areas of Southeast Asia, where resistance has emerged, P. falciparum antibodies confound parasite clearance measures. However, variation in naturally acquired antibodies across Asian and sub-Saharan African epidemiological contexts and their impact on parasite clearance re yet to be quantified. METHODS: In an artemisinin therapeutic efficacy study, antibodies to 12 pre-erythrocytic and erythrocytic P. falciparum antigens were measured in 118 children with uncomplicated P. falciparum malaria in the Democratic Republic of Congo (DRC) and compared with responses in patients from Asian sites, described elsewhere. RESULTS: Parasite clearance half-life was shorter in DRC patients (median, 2 hours) compared with most Asian sites (median, 2-7 hours), but P. falciparum antibody levels and seroprevalences were similar. There was no evidence for an association between antibody seropositivity and parasite clearance half-life (mean difference between seronegative and seropositive, -0.14 to +0.40 hour) in DRC patients. CONCLUSIONS: In DRC, where artemisinin remains highly effective, the substantially shorter parasite clearance time compared with Asia was not explained by differences in the P. falciparum antibody responses studied.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Cutts JC, O'Flaherty K, Zaloumis SG, et al. Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia. J Infect Dis. 2022. PMID: 35703955. doi:10.1093/infdis/jiac232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。